Transcription of Pharmaceutical Serialization: An Implementation Guide
{{id}} {{{paragraph}}}
Pharmaceutical serialization : An Implementation GuideBy Joe Whyte, global serialization Lead, Rockwell AutomationGlobal Pharmaceutical companies lose an estimated $75 billion annually to counterfeit, gray market and stolen product. Impending regulations aimed at protecting public health, intellectual property and national security will require Pharmaceutical , medical device and consumer packaged-goods manufacturers to track and trace products across the supply white paper gives in-depth descriptions of the: Challenges driving new serialization regulation. Pending regulation requirements and deadlines. Implementation and interoperability challenges in Pharmaceutical serialization solutions.
Global pharmaceutical companies lose an estimated $75 billion annually to counterfeit, gray market and stolen product. Impending regulations aimed at protecting public health, intellectual property and national security will require pharmaceutical, medical device and consumer packaged-goods manufacturers to track and trace products across the
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}